Effectiveness and safety with tenofovir alafenamide (TAF) for hepatitis B in US clinical practice Curry, M., Bae, H., Dieterich, D., Ankoma-Sey, V., Reddy, R., Pan, C., Hann, H., Tong, M., Kim, W., Kwo, P., Frazier, L., Milligan, S., Spitz, K., Afdhal, N. ELSEVIER SCIENCE BV. 2019: E462

View details for Web of Science ID 000463481701494